Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1440]
News [2204]
Articles [39]
Editorials [5]
Conferences [149]
elearning [0]
Ramucirumab for gastric cancer does not get UK approval
Ramucirumab for gastric cancer does not get UK approval
UK approval for panobinostat as a possible treatment for multiple myeloma
UK approval for panobinostat as a possible treatment for multiple myeloma
New options for prostate cancer as radium 223 dichloride is approved in the UK
New options for prostate cancer as radium 223 dichloride is approved in the UK
NICE approves olaparib for ovarian cancer
NICE approves olaparib for ovarian cancer
NHS England approves upfront docetaxel for advanced prostate cancer
NHS England approves upfront docetaxel for advanced prostate cancer
Making the tobacco industry pay for the health damage caused by smoking
Making the tobacco industry pay for the health damage caused by smoking
Pembrolizumab label updated with new clinical trial information in melanoma
Pembrolizumab label updated with new clinical trial information in melanoma
Drug shows potential as safe and effective for most prevalent form of adult leukaemia
Drug shows potential as safe and effective for most prevalent form of adult leukaemia
ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma
ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma
Price of cancer drugs varies by up to 388% between European countries, Australia, and New Zealand
Price of cancer drugs varies by up to 388% between European countries, Australia, and New Zealand

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation